Dizal Pharma receives $600 million upfront payment from AstraZeneca; Dongyangguang controlling shareholder proposes buyback of up to 1.2 billion yuan

上海证券报··CNGB·Read original
4▲4 ▼0Impact / 5
Summary · why it matters

Dizal Pharma has recently received a $600 million upfront payment from AstraZeneca. The company signed a license agreement with AstraZeneca on July 14, granting it exclusive global rights to develop and commercialize sunvozertinib, and the agreement officially took effect on August 31. Dongyangguang announced that its controlling shareholder, Shenzhen Dongyangguang Industrial, has proposed that the company use its own or self-raised funds to repurchase its A-shares through the Shanghai Stock Exchange system by centralized bidding, with a repurchase amount of no less than 600 million yuan and no more than 1.2 billion yuan. The repurchase price will not exceed 150% of the average trading price of the stock over the 30 trading days before the board resolution, and the implementation period is within six months after board approval. Shandong Gold Mining Chairman Wang Chenglong proposed using 300 million to 400 million yuan to repurchase company shares, which will be cancelled to reduce the company's registered capital. Bomesc Offshore Engineering's wholly owned subsidiary Tianjin Bomesc signed a contract with Single Buoy Moorings Inc. for the construction of topside modules for a floating production storage and offloading vessel, with a contract value of approximately 1.6 billion to 2.1 billion yuan, roughly equivalent to Bomesc's full-year 2025 revenue of 1.9 billion yuan. Changyingtong recently received a purchase order from a customer for polarization-maintaining fiber products, with a tentative total amount of 147 million yuan including tax.

Impact on assets 7

Biotech & Genomic Medicine▲ · 1 stocks
AstraZeneca PLC
AZN
▲ PositiveCapitalrelevance

Signed a license agreement granting exclusive global rights to develop and commercialize sunvozertinib, paying $600 million upfront to Dizal.

Energy▲ · 1 stocks
Others▲ · 5 stocks
Bomesc Offshore Engineering Co
603727
▲ PositiveDemandrelevance

Wholly owned subsidiary Tianjin Bomesc signed a ~1.6-2.1 billion yuan contract for FPSO topside modules, roughly equal to full-year 2025 revenue.

Off-coverage companies 1

天津博迈科海洋工程有限公司Private± Mixed
relevance

© 2026 MarketIVNews